ES2127106B1 - Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. - Google Patents
Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.Info
- Publication number
- ES2127106B1 ES2127106B1 ES009600682A ES9600682A ES2127106B1 ES 2127106 B1 ES2127106 B1 ES 2127106B1 ES 009600682 A ES009600682 A ES 009600682A ES 9600682 A ES9600682 A ES 9600682A ES 2127106 B1 ES2127106 B1 ES 2127106B1
- Authority
- ES
- Spain
- Prior art keywords
- sup
- sub
- group
- derivatives
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003042 antagnostic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- -1 5-tetrazolyl group Chemical group 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001562 benzopyrans Chemical class 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 abstract 1
- 150000002617 leukotrienes Chemical class 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Derivados benzopiránicos con acción antagonista de los leucotrienos, procedimiento para su preparación y utilización de los mismos. La invención describe derivados de fórmula I, A es un átomo de oxígeno, azufre o un grupo metileno; B y C son: a) cuando B es un heterociclo benzofusionado, U es un átomo de oxígeno, azufre o nitrógeno, Z-Y son átomos de carbono unidos por un enlace doble o sencillo y T es un enlace sencillo, un grupo metileno o carbonilo, C puede ser un grupo -CON{sup,7 R-, CSNR{sup,7 -, SO{sub,2 NR{sup,7 -, CH{sub,2 O-, -CH=CH-; b) cuando B es un grupo fenilo, C puede ser un grupo -SO{sub,2 NR{sup,7 -, CH{sub,2 O-, -CH=CH-; D es un grupo 5-tetrazolilo o -COOR{sup,8 , R{sup,8 es hidrógeno, (C{sub,1 -C{sub,4 )-alquilo o un grupo fenilalquilo; m y n son enteros entre 0 y 4. Presentan acción antagonista de los leucotrienos. Son utilizados como antiinflamatorios, antialérgicos o para tratamiento de enfermedades cardiovasculares.
Priority Applications (32)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009600682A ES2127106B1 (es) | 1996-03-21 | 1996-03-21 | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. |
UA98094930A UA65535C2 (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives and a method for the preparation thereof |
GEAP19974493A GEP20012416B (en) | 1996-03-21 | 1997-03-20 | Benzopyran Derivatives Having Leukotriene-Antagonistic Action |
PCT/EP1997/001418 WO1997034885A1 (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
EP97914280A EP0888327B1 (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
SK1272-98A SK282979B6 (sk) | 1996-03-21 | 1997-03-20 | Benzopyránové deriváty, spôsob ich prípravy a ich použitie |
AU21587/97A AU707282B2 (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
CA002249402A CA2249402C (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
CNB971931933A CN1182129C (zh) | 1996-03-21 | 1997-03-20 | 具有白细胞三烯拮抗作用的苯并吡喃衍生物 |
ES97914280T ES2176719T3 (es) | 1996-03-21 | 1997-03-20 | Derivados de benzopirano que tienen una accion antagonista de leucotrienos. |
BR9708215-5A BR9708215A (pt) | 1996-03-21 | 1997-03-20 | Derivados de benzopirano contendo ação antagonista de leucotrieno. |
IL12629697A IL126296A (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene antagonistic action, their preparation and pharmaceutical compositions containing them |
TR1998/01857T TR199801857T2 (xx) | 1996-03-21 | 1997-03-20 | L�kotrien-antagonistik etkisine sahip olan benzopiran t�revleri. |
DE69713300T DE69713300T2 (de) | 1996-03-21 | 1997-03-20 | Benzopyran derivate mit leukotrien-antagonistischer wirkung |
KR10-1998-0707399A KR100378892B1 (ko) | 1996-03-21 | 1997-03-20 | 류코트리엔-길항활성을갖는벤조피란유도체 |
EA199800738A EA001680B1 (ru) | 1996-03-21 | 1997-03-20 | Производные бензопирана, обладающие антагонистическим действием в отношении лейкотриена |
HU9901326A HUP9901326A3 (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions |
CZ0299598A CZ296260B6 (cs) | 1996-03-21 | 1997-03-20 | Benzopyranové deriváty, zpusob jejich výroby a farmaceutický prostredek |
SI9730340T SI0888327T1 (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
DK97914280T DK0888327T3 (da) | 1996-03-21 | 1997-03-20 | Benzopyranderivater, som har antagonistisk virkning imod leukotriener |
NZ331953A NZ331953A (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
PT97914280T PT888327E (pt) | 1996-03-21 | 1997-03-20 | Derivados de benzopirano que possuem uma accao antagonistica dos leucotrienos |
US09/142,922 US5990142A (en) | 1996-03-21 | 1997-03-20 | Benzopyran derivatives having leukotriene-antagonistic action |
EE9800318A EE03526B1 (et) | 1996-03-21 | 1997-03-20 | Leukotrieen-antagonistliku toimega bensopüraanderivaadid, nende valmistamismeetod ja kasutamine |
AT97914280T ATE219073T1 (de) | 1996-03-21 | 1997-03-20 | Benzopyran derivate mit leukotrien- antagonistischer wirkung |
JP53315997A JP3914575B2 (ja) | 1996-03-21 | 1997-03-20 | ロイコトリエンアンタゴニスト作用を有するベンゾピラン誘導体 |
PL97329027A PL189562B1 (pl) | 1996-03-21 | 1997-03-20 | Pochodne benzopiranu o działaniu antagonistycznymdla leukotrienu i sposób ich wytwarzania |
BG102775A BG63433B1 (bg) | 1996-03-21 | 1998-09-17 | Бензопиранови производни, имащи антагонистично действие спрямо левкотриени |
NO19984330A NO319612B1 (no) | 1996-03-21 | 1998-09-17 | Benzopyranderivater som har leukotrien-antagonistisk virkning, fremgangsmate for fremstilling og anvendelse derav |
YUP-407/98A RS49588B (sr) | 1996-03-21 | 1998-09-18 | Derivati benzopirana koji poseduju leukotrien-antagonističko dejstvo |
CU1998130A CU22777A3 (es) | 1996-03-21 | 1998-09-18 | Derivados de benzopirano que tienen acción antagonista para el leucotrieno |
HK99103747A HK1018701A1 (en) | 1996-03-21 | 1999-08-31 | Benzopyran derivatives having leukotriene-antagonistic action. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009600682A ES2127106B1 (es) | 1996-03-21 | 1996-03-21 | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2127106A1 ES2127106A1 (es) | 1999-04-01 |
ES2127106B1 true ES2127106B1 (es) | 1999-11-16 |
Family
ID=8294261
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009600682A Expired - Lifetime ES2127106B1 (es) | 1996-03-21 | 1996-03-21 | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. |
ES97914280T Expired - Lifetime ES2176719T3 (es) | 1996-03-21 | 1997-03-20 | Derivados de benzopirano que tienen una accion antagonista de leucotrienos. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97914280T Expired - Lifetime ES2176719T3 (es) | 1996-03-21 | 1997-03-20 | Derivados de benzopirano que tienen una accion antagonista de leucotrienos. |
Country Status (31)
Country | Link |
---|---|
US (1) | US5990142A (es) |
EP (1) | EP0888327B1 (es) |
JP (1) | JP3914575B2 (es) |
KR (1) | KR100378892B1 (es) |
CN (1) | CN1182129C (es) |
AT (1) | ATE219073T1 (es) |
AU (1) | AU707282B2 (es) |
BG (1) | BG63433B1 (es) |
BR (1) | BR9708215A (es) |
CA (1) | CA2249402C (es) |
CU (1) | CU22777A3 (es) |
CZ (1) | CZ296260B6 (es) |
DE (1) | DE69713300T2 (es) |
DK (1) | DK0888327T3 (es) |
EA (1) | EA001680B1 (es) |
EE (1) | EE03526B1 (es) |
ES (2) | ES2127106B1 (es) |
GE (1) | GEP20012416B (es) |
HK (1) | HK1018701A1 (es) |
HU (1) | HUP9901326A3 (es) |
IL (1) | IL126296A (es) |
NO (1) | NO319612B1 (es) |
NZ (1) | NZ331953A (es) |
PL (1) | PL189562B1 (es) |
PT (1) | PT888327E (es) |
RS (1) | RS49588B (es) |
SI (1) | SI0888327T1 (es) |
SK (1) | SK282979B6 (es) |
TR (1) | TR199801857T2 (es) |
UA (1) | UA65535C2 (es) |
WO (1) | WO1997034885A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1232285B1 (en) | 1999-11-24 | 2008-06-04 | The Research Foundation Of State University of New York | CATALYTIC RNAs WITH AMINOACYLATION ACTIVITY |
ATE437946T1 (de) * | 2002-02-15 | 2009-08-15 | Univ New York State Res Found | Ribozyme mit breiter trna-aminoacylierungswirkung |
US7851486B2 (en) | 2002-10-17 | 2010-12-14 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment |
EP1579010A4 (en) * | 2002-10-17 | 2010-07-21 | Decode Genetics Ehf | SUSCEPTIBILITY GENE FOR MYOCARDIAL INFARCTION AND METHODS OF TREATMENT |
ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
CA2580584C (en) * | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
AP2006003700A0 (en) | 2004-02-13 | 2006-08-31 | Warner Lambert Co | Androgen receptor modulators |
CN100475781C (zh) * | 2004-02-13 | 2009-04-08 | 沃尼尔·朗伯有限责任公司 | 雄激素受体调节剂 |
WO2005100305A1 (en) | 2004-04-13 | 2005-10-27 | Warner-Lambert Company Llc | Androgen modulators |
JP4874965B2 (ja) * | 2004-07-08 | 2012-02-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン調節剤 |
CA2573457A1 (en) * | 2004-08-18 | 2006-02-23 | Warner-Lambert Company Llc | 4-(2-methoxy-phenoxy)-2-trifluoromethyl-benzonitrile as an androgen modulator |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
US20090170886A1 (en) * | 2005-08-08 | 2009-07-02 | Pfizer Inc | Androgen modulators |
EP1964916B1 (en) * | 2005-12-06 | 2012-08-01 | The University of Tokyo | Multi-purpose acylation catalayst and use thereof |
ITMI20061606A1 (it) * | 2006-08-09 | 2008-02-10 | Dipharma Spa | Procedimento per la preparazione di composti nitrilici |
CN102304052A (zh) * | 2011-07-28 | 2012-01-04 | 浙江大学 | 一种制备5-溴-2-羟基-3-硝基苯乙酮的方法 |
CN103980257B (zh) * | 2014-05-28 | 2016-04-27 | 苏州开元民生科技股份有限公司 | 8-硝基-2-四氮唑基-4-羰基苯并吡喃的合成方法 |
CN104402711A (zh) * | 2014-11-12 | 2015-03-11 | 平湖优康药物研发有限公司 | 一种抗哮喘药物普伦斯特中间体的合成工艺 |
CN113651788B (zh) * | 2021-09-16 | 2023-11-21 | 东华理工大学 | 一种3-胺烷基色酮化合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4977162A (en) * | 1989-07-13 | 1990-12-11 | Rorer Pharmaceutical Corporation | Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments |
JPH0395144A (ja) * | 1989-08-04 | 1991-04-19 | Ono Pharmaceut Co Ltd | アミノフェノール誘導体の製造方法 |
-
1996
- 1996-03-21 ES ES009600682A patent/ES2127106B1/es not_active Expired - Lifetime
-
1997
- 1997-03-20 AT AT97914280T patent/ATE219073T1/de not_active IP Right Cessation
- 1997-03-20 CN CNB971931933A patent/CN1182129C/zh not_active Expired - Fee Related
- 1997-03-20 SK SK1272-98A patent/SK282979B6/sk not_active IP Right Cessation
- 1997-03-20 DE DE69713300T patent/DE69713300T2/de not_active Expired - Fee Related
- 1997-03-20 UA UA98094930A patent/UA65535C2/uk unknown
- 1997-03-20 PT PT97914280T patent/PT888327E/pt unknown
- 1997-03-20 HU HU9901326A patent/HUP9901326A3/hu unknown
- 1997-03-20 KR KR10-1998-0707399A patent/KR100378892B1/ko not_active IP Right Cessation
- 1997-03-20 SI SI9730340T patent/SI0888327T1/xx unknown
- 1997-03-20 NZ NZ331953A patent/NZ331953A/xx not_active IP Right Cessation
- 1997-03-20 PL PL97329027A patent/PL189562B1/pl not_active IP Right Cessation
- 1997-03-20 ES ES97914280T patent/ES2176719T3/es not_active Expired - Lifetime
- 1997-03-20 EE EE9800318A patent/EE03526B1/xx not_active IP Right Cessation
- 1997-03-20 JP JP53315997A patent/JP3914575B2/ja not_active Expired - Fee Related
- 1997-03-20 GE GEAP19974493A patent/GEP20012416B/en unknown
- 1997-03-20 CZ CZ0299598A patent/CZ296260B6/cs not_active IP Right Cessation
- 1997-03-20 IL IL12629697A patent/IL126296A/en not_active IP Right Cessation
- 1997-03-20 EA EA199800738A patent/EA001680B1/ru unknown
- 1997-03-20 WO PCT/EP1997/001418 patent/WO1997034885A1/en active IP Right Grant
- 1997-03-20 AU AU21587/97A patent/AU707282B2/en not_active Ceased
- 1997-03-20 TR TR1998/01857T patent/TR199801857T2/xx unknown
- 1997-03-20 BR BR9708215-5A patent/BR9708215A/pt not_active Application Discontinuation
- 1997-03-20 US US09/142,922 patent/US5990142A/en not_active Expired - Fee Related
- 1997-03-20 DK DK97914280T patent/DK0888327T3/da active
- 1997-03-20 EP EP97914280A patent/EP0888327B1/en not_active Expired - Lifetime
- 1997-03-20 CA CA002249402A patent/CA2249402C/en not_active Expired - Fee Related
-
1998
- 1998-09-17 NO NO19984330A patent/NO319612B1/no not_active IP Right Cessation
- 1998-09-17 BG BG102775A patent/BG63433B1/bg unknown
- 1998-09-18 CU CU1998130A patent/CU22777A3/es not_active IP Right Cessation
- 1998-09-18 RS YUP-407/98A patent/RS49588B/sr unknown
-
1999
- 1999-08-31 HK HK99103747A patent/HK1018701A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2127106B1 (es) | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. | |
ES2075121T3 (es) | Nuevos compuestos triciclicos. | |
BR9714023A (pt) | Derivados de 3,4 - dihidroantraceno arila ou heteroarila substituìda ou benzo [1,2-g]- crom - 3 - eno arila ou heteroarila substituìda ou benzo [1,2-g]- tiocrom-3-eno e benzo[1,2-g]-1,2- dihidroquinolina tendo atividade biológica tipo antagonista de retinóide ou agonista inverso de retinóide | |
NO853261L (no) | Fremgangsmaate for fremstilling av benz(tio)amider | |
EA200300391A1 (ru) | Имидазольные соединения, арил- или гетероарилконденсированные, в качестве противовоспалительных и анальгетических средств | |
DE60143493D1 (de) | 2-Oxo-1-Pyrrolidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung. | |
ATE339408T1 (de) | Terphenylderivate, deren herstellung und zusammensetzungen, die diese enthalten | |
DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
DE69617731D1 (de) | Neue heterozyklische derivate und ihre medizinische anwendung | |
GB2303851A (en) | Pharmaceutical diketopiperazine compounds | |
DE3462504D1 (de) | Indole-3-carboxamide derivatives | |
ES2136782T3 (es) | Procedimiento para producir compuestos de acido quinolin-2-il-benzoico. | |
AR023111A1 (es) | Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden | |
BR9508436A (pt) | Dihidro benzofurando e compostos correlacionados úteis como agentes anti-inflamatórios | |
ES2145339T3 (es) | Composiciones para estabilizar polimeros sinteticos. | |
EA199901050A2 (ru) | Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции | |
ES2165067T3 (es) | Nuevos derivados aromaticos sustituidos con una ribosa, su procedimiento de preparacion y su aplicacion como medicamentos. | |
ATE293600T1 (de) | Antibakterielle mittel | |
ATE307103T1 (de) | Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen | |
DE59907215D1 (de) | Substituierte benzimidazole, ihre herstellung und ihre verwendung als mittel gegen parasitäre protozoen | |
EA200000631A1 (ru) | Дериватизированные из азациклоалканов уретаны, их тио- и дитионалоги, их получение и их применение в качестве ингибиторов 2,3-эпоксисквален-ланостерин-циклазы | |
IT1199339B (it) | N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono | |
NO20021162L (no) | 5-aminoalkyl og 5-aminokarbonyl-substituerte indoler | |
AR030009A1 (es) | Eteres de vinilarilo de propiedades herbicidas , composiciones y productos formulados con dichos compuestos; metodos para controlar malezas en un lugar aplicando dichas composiciones; metodos para reducir la fitotoxicidad de dichos compuestos sobre las gramineas y procesos para preparar los compuest | |
DK0386778T3 (da) | Biphenylderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19990401 Kind code of ref document: A1 Effective date: 19990401 |